Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Estimated Value: $10,000,000
Open Healthcaregrant
Aug 28, 2025
Healthcare
grant
AI Summary
This funding opportunity is for a clinical trial focused on expanded access to treatments for an intermediate patient population with Amyotrophic Lateral Sclerosis (ALS). The funding is intended to support the research and execution of the clinical trial.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Clinical Trial Research Services 1 lot $2,000,000.00 $2,000,000.00 Professional Services
Patient Recruitment and Enrollment Services 1 lot $1,000,000.00 $1,000,000.00 Medical
ALS Treatment Drugs/Placebo 1 lot $3,000,000.00 $3,000,000.00 Medical
Medical Monitoring and Safety Reporting Services 1 lot $500,000.00 $500,000.00 Medical
Data Management and Statistical Analysis Services 1 lot $1,500,000.00 $1,500,000.00 IT Services
Laboratory Services (Biomarker Analysis, etc.) 1 lot $1,000,000.00 $1,000,000.00 Medical
Project Management Services 1 lot $1,000,000.00 $1,000,000.00 Professional Services
Estimated Bid Value$10,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids